Parnax Lab Ltd
Ticker: PARNAXLAB
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
129.15
Market Cap
148.34
Debt/Equity
0.8353
ROE %
14.870
PB
1.7820
Promoter %
72.297
Pledge %
6.804
1Y Rev Growth %
-0.058
5Y Rev Growth %
14.567
NP Margin %
6.082
NP Margin 5Y Avg %
4.181
Trading Reference
1M Return %
-5.366
6M Return %
29.085
1Y Return %
-5.037
% Away 52W High
49.826
% Away 52W Low
59.444
Daily Volume
24582
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 33/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Parnax Lab Ltd is currently trading near a significant support level, with recent volume indicating accumulation. If it breaks above the resistance level identified by the 50-day EMA, there is potential for upward momentum. However, if it falls below the support level, downside risk increases.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
K
Kesoram Industries Ltd
Kesoram Industries Ltd presents a risky investment with inconsistent growth and profitability metrics, alongside financial concerns.
View details
C
Chetana Education Ltd
Chetana Education Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation. Investors should proceed with caution.
View details
M
Mukta Arts Ltd
Mukta Arts Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
Z
Zenith Exports Ltd
Zenith Exports Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sellowrap Industries Ltd
Sellowrap Industries Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised.
View details
B
B D Industries (Pune) Ltd
B D Industries shows potential with a decent business model and growth prospects, but faces challenges in profitability and market sentiment.
View details
L
Lahoti Overseas Ltd
Lahoti Overseas Ltd shows potential but faces challenges in profitability and market sentiment.
View details
S
Sharp India Ltd
Sharp India Ltd shows potential in a future-ready sector but faces significant challenges in growth consistency and market sentiment.
View details
H
HEC Infra Projects Ltd
HEC Infra Projects Ltd shows potential in a growing sector, but faces challenges in execution and profitability that may hinder growth.
View details
M
Marvel Decor Ltd
Marvel Decor Ltd shows potential in a growing sector but faces significant challenges in profitability and market sentiment, making it a risky investment.
View details
S
Slone Infosystems Ltd
Slone Infosystems Ltd shows potential but faces challenges in profitability and market sentiment. Caution is advised.
View details
R
Rappid Valves (India) Ltd
Rappid Valves (India) Ltd shows potential for growth, but faces challenges in profitability and market competition.
View details
S
Sarthak Metals Ltd
Sarthak Metals Ltd shows potential but faces challenges in growth and profitability metrics. Caution is advised.
View details
K
KHFM Hospitality and Facility Management Services Ltd
KHFM Hospitality and Facility Management Services Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
S
Surani Steel Tubes Ltd
Surani Steel Tubes Ltd shows potential but faces several challenges that could impact future performance.
View details
K
Kaira Can Co Ltd
Kaira Can Co Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Parnax Lab Ltd is a leading player in the pharmaceutical sector, dedicated to developing high-quality healthcare products. Catering primarily to the Indian market, the company focuses on enhancing patient outcomes through innovative solutions. Parnax Lab is committed to maintaining stringent quality standards and regulatory compliance, ensuring trust and reliability in its offerings. With a strong emphasis on research and development, Parnax Lab is poised to address the evolving healthcare needs of the nation.
- Established reputation in the pharmaceutical industry
- Focus on innovative healthcare solutions
- Commitment to quality and compliance
- Strong R&D capabilities
- Dedicated to improving patient outcomes
Investment Thesis
Parnax Lab Ltd presents a compelling investment opportunity driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to its peers. This combination positions the company for robust future performance, making it a worthy addition to any investor's portfolio.
- Strong promoter group with a history of successful ventures.
- Significant growth runway in digital services and innovation.
- Attractive valuation compared to industry peers, enhancing upside potential.
- Focus on sustainability and quality, appealing to modern consumers.
- Strategic partnerships to boost market presence and revenue streams.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into international markets
- Strong R&D pipeline
- Potential for strategic partnerships
Risks ⚠️
- Regulatory challenges in healthcare
- High competition in the sector
- Dependence on key suppliers
- Market volatility affecting stock price
Peer Perspective
Parnax Lab Ltd trades at a premium to peers like Granules India and Aarti Drugs, reflecting its robust growth potential. A sustained improvement in margin stability could trigger a significant rerating in its valuation.
Future Outlook
Parnax Lab Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities; however, successful execution and cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Parnax Lab Ltd do?A: Parnax Lab Ltd is involved in pharmaceutical research and development, focusing on innovative drug formulations.
- Q: Is Parnax Lab Ltd listed on stock exchanges?A: Yes, Parnax Lab Ltd is listed on major stock exchanges, making it accessible for investors.
- Q: What are the risks of investing in Parnax Lab Ltd?A: Investing in Parnax Lab Ltd carries risks typical of the pharmaceutical sector, including regulatory and market challenges.
- Q: How can I buy shares of Parnax Lab Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What factors influence Parnax Lab Ltd's stock price?A: Factors include company performance, market trends, regulatory news, and overall economic conditions.
📊 Stock Investment Checklist (100 Points)
Parnax Lab Ltd • Updated: 2025-09-17 15:03:03
-
10BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighRevenue growth has been inconsistent over the past few quarters.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating lower efficiency.
-
8ValuationHighP/E ratio is higher than peers, suggesting overvaluation.
-
7BalanceHighModerate debt levels but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth drivers identified; execution risks are high.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Parnax Lab Ltd shows potential in a growing sector but faces significant challenges in growth consistency and profitability metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100